Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The bone and joint decade 2000-2010.

Literature DB >> 10648008

The bone and joint decade 2000-2010.

J M Hazes, A D Woolf.

Abstract

Mesh：

Year: 2000 PMID： 10648008

Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. [Increase of musculoskeletal pain in Austria--what are we waiting for?].

Authors: Reinhard Windhager
Journal: Wien Klin Wochenschr Date: 2006-03 Impact factor: 1.704

2. The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity.

Authors: Klaus P Machold; Marcus D Köller; Stephan Pflugbeil; Christof Zimmermann; Ernst Wagner; Ulrike Stuby; Daniel Aletaha; Tanja A Stamm; Franz Mayrhofer; Attila Dunky; Josef Hermann; Wilfried Ilias; Josef S Smolen
Journal: Ann Rheum Dis Date: 2007-01-04 Impact factor: 19.103

3. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

Authors: D L Scott; J S Smolen; J R Kalden; L B van de Putte; A Larsen; T K Kvien; M Schattenkirchner; P Nash; C Oed; I Loew-Friedrich
Journal: Ann Rheum Dis Date: 2001-10 Impact factor: 19.103

4. Assessment of the general public's knowledge about rheumatic diseases: evidence from a Portuguese population-based survey.

Authors: Milton Severo; Rita Gaio; Raquel Lucas; Henrique Barros
Journal: BMC Musculoskelet Disord Date: 2010-09-16 Impact factor: 2.362

The bone and joint decade 2000-2010.

1. [Increase of musculoskeletal pain in Austria--what are we waiting for?].

2. The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity.

3. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

4. Assessment of the general public's knowledge about rheumatic diseases: evidence from a Portuguese population-based survey.

Review 5. The burden of musculoskeletal disease--a global perspective.

Review 6. The WHO-ILAR COPCORD Bhigwan (India) model: foundation for a future COPCORD design and data repository.

7. Real patient learning integrated in a preclinical block musculoskeletal disorders. Does it make a difference?